Hepatic Xenetix-CT Perfusion

Clinical trial NCT01639703 · COMPLETED

Trial details

NCT number: NCT01639703
Sponsor: Guerbet
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2012-04-01
Primary completion: 2014-10-01
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.